[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:hif-2":3},{"name":4,"total":5,"recruiting":5,"trials":6},"HIF-2α",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04924075","Belzutifan\u002FMK-6482 for the Treatment of Advanced Pheochromocytoma\u002FParaganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)",[11],"Phase 2","RECRUITING","2026-08-26T02:17:01.714035Z","2026-07-05T05:32:16.796442Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07641881","A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Participants",[19],"Phase 1","2026-08-03T03:32:10.191597Z","2026-06-14T18:39:22.260597Z"]